{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:44:10Z","timestamp":1789425850646,"version":"build-2803163510"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.prp.2025.156068","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:30:46Z","timestamp":1748892646000},"page":"156068","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Immunohistochemical biomarker scoring in gastroesophageal cancers: Can computers help us?"],"prefix":"10.1016","volume":"272","author":[{"given":"Alessandro","family":"Caputo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Angerilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gambella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"L\u2019Imperio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Taffon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Milione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mastracci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vanoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Fassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.156068_bib1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41416-020-01122-x","article-title":"Deep learning in cancer pathology: a new generation of clinical biomarkers","volume":"124","author":"Echle","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2025.156068_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100589","article-title":"Claudin-18.2 immunohistochemical evaluation in gastric and gastroesophageal junction adenocarcinomas to direct targeted therapy: a practical approach","volume":"37","author":"Fassan","year":"2024","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2025.156068_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/14737159.2023.2288267","article-title":"A charming molecular profile in the wrong tissue: the pathologist in the era of molecular diagnostics in the gastrointestinal tract","volume":"23","author":"Parente","year":"2023","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.prp.2025.156068_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104427","article-title":"Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade","volume":"88","author":"Berb\u00eds","year":"2023","journal-title":"eBioMedicine"},{"key":"10.1016\/j.prp.2025.156068_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.humpath.2022.07.008","article-title":"Artificial intelligence in anatomical pathology: building a strong foundation for precision medicine","volume":"132","author":"Meroueh","year":"2023","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2025.156068_bib6","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/his.14659","article-title":"The future of artificial intelligence in digital pathology \u2013 results of a survey across stakeholder groups","volume":"80","author":"Heinz","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.156068_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.5858\/arpa.2018-0043-OA","article-title":"Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer","volume":"143","author":"Kulangara","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2025.156068_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40265-020-01286-z","article-title":"Tislelizumab: first approval","volume":"80","author":"Lee","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.prp.2025.156068_bib9","article-title":"Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial","volume":"385","author":"Qiu","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.prp.2025.156068_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa2111380","article-title":"Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma","volume":"386","author":"Doki","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2025.156068_bib11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.32074\/1591-951X-803","article-title":"PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application","volume":"114","author":"Mastracci","year":"2022","journal-title":"Pathologica"},{"key":"10.1016\/j.prp.2025.156068_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.32074\/1591-951X-836","article-title":"A practical approach for PD-L1 evaluation in gastroesophageal cancer","volume":"115","author":"Angerilli","year":"2023","journal-title":"Pathologica"},{"key":"10.1016\/j.prp.2025.156068_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13000-023-01318-8","article-title":"Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring","volume":"18","author":"Liu","year":"2023","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prp.2025.156068_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.32074\/1591-951X-158","article-title":"Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice","volume":"112","author":"Fassan","year":"2020","journal-title":"Pathologica"},{"key":"10.1016\/j.prp.2025.156068_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00428-019-02693-8","article-title":"PD-L1 expression in gastroesophageal dysplastic lesions","volume":"477","author":"Fassan","year":"2020","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2025.156068_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12935-020-01273-0","article-title":"Heterogeneous programmed death-ligand 1 expression in gastric cancer: comparison of tissue microarrays and whole sections","volume":"20","author":"Ye","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.prp.2025.156068_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13000-018-0766-0","article-title":"PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28\u20138 and E1L3N)","volume":"13","author":"Ma","year":"2018","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prp.2025.156068_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00428-019-02653-2","article-title":"PD-L1 expression in gastric cancer determined by digital image analyses: pitfalls and correlation with pathologist interpretation","volume":"476","author":"Kim","year":"2020","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2025.156068_bib19","article-title":"Performance validation of an artificial intelligence-powered PD-L1 combined positive score analyzer in six cancer types","volume":"41","author":"Lee","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.156068_bib20","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1200\/JCO.2024.42.16_suppl.2633","article-title":"AI based PD-L1 CPS quantifier software to identify more patients for checkpoint therapy in gastric cancer at pathologist-level interobserver concordance","volume":"42","author":"Badve","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.156068_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1158\/2767-9764.CRC-23-0287","article-title":"Weakly Supervised Deep Learning Predicts Immunotherapy Response in Solid Tumors Based on PD-L1 Expression","volume":"4","author":"Ligero","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.prp.2025.156068_bib22","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.15_suppl.e16518","article-title":"Pathologic validation of artificial intelligence-powered prediction of combined positive score of PD-L1 immunohistochemistry in urothelial carcinoma","volume":"39","author":"Park","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.156068_bib23","first-page":"380","article-title":"Comparison of continuous measures across diagnostic PD-L1 assays in non-small cell lung cancer using automated image analysis","volume":"33","author":"Widmaier","year":"2020","journal-title":"Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc."},{"key":"10.1016\/j.prp.2025.156068_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41523-021-00268-y","article-title":"How can artificial intelligence models assist PD-L1 expression scoring in breast cancer: results of multi-institutional ring studies","volume":"7","author":"Wang","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.prp.2025.156068_bib25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s12967-024-05262-z","article-title":"Deep learning based digital pathology for predicting treatment response to first-line PD-1 blockade in advanced gastric cancer","volume":"22","author":"Liu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2025.156068_bib26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12967-024-04997-z","article-title":"From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2025.156068_bib27","article-title":"Multimodal deep learning for predicting PD-L1 biomarker and clinical immunotherapy outcomes of esophageal cancer","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2025.156068_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100921","article-title":"Using deep learning to predict anti-PD-1 response in melanoma and lung cancer patients from histopathology images","volume":"14","author":"Hu","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.prp.2025.156068_bib29","article-title":"Deep learning model for predicting immunotherapy response in advanced non\u2212small cell lung cancer","author":"Rakaee","year":"2024","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.prp.2025.156068_bib30","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1038\/s41467-022-34275-9","article-title":"Deep learning-based image analysis predicts PD-L1 status from H&E-stained histopathology images in breast cancer","volume":"13","author":"Shamai","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2025.156068_bib31","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2016.69.4836","article-title":"HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology","volume":"35","author":"Bartley","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.156068_bib32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2025.156068_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00428-018-2502-2","article-title":"Intratumoral HER2 heterogeneity in early gastric carcinomas: potential bias in therapeutic management","volume":"474","author":"Ieni","year":"2019","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2025.156068_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/his.15346","article-title":"Discordance of human epidermal growth factor receptor 2-low status between breast primary and distant metastases with clinical\u2013pathological correlation","volume":"86","author":"Yang","year":"2025","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.156068_bib35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2559.2012.04272.x","article-title":"Early HER2 dysregulation in gastric and oesophageal carcinogenesis","volume":"61","author":"Fassan","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.156068_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/cam4.365","article-title":"Reproducibility of Her2\/neu scoring in gastric cancer and assessment of the 10% cut-off rule","volume":"4","author":"Behrens","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.prp.2025.156068_bib37","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.5858\/arpa.2013-0604-OA","article-title":"HER2\/neu Testing in Gastric Cancer by Immunohistochemistry: assessment of Interlaboratory Variation","volume":"138","author":"Sheffield","year":"2014","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2025.156068_bib38","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.3390\/cancers16152761","article-title":"The performance and clinical applicability of her2 digital image analysis in breast cancer: a systematic review","volume":"16","author":"Dunenova","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.156068_bib39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5230\/jgc.2023.23.e25","article-title":"Artificial intelligence in the pathology of gastric cancer","volume":"23","author":"Choi","year":"2023","journal-title":"J. Gastric Cancer"},{"key":"10.1016\/j.prp.2025.156068_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.877229","article-title":"A Deep learning quantification algorithm for HER2 scoring of gastric cancer","volume":"16","author":"Han","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.prp.2025.156068_bib41","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41416-023-02143-y","article-title":"Predicting the HER2 status in oesophageal cancer from tissue microarrays using convolutional neural networks","volume":"128","author":"Pisula","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2025.156068_bib42","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/his.13333","article-title":"HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissues","volume":"72","author":"Qaiser","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2025.156068_bib43","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2021.39.15_suppl.3061","article-title":"Machine learning models to quantify HER2 for real-time tissue image analysis in prospective clinical trials","volume":"39","author":"Glass","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.156068_bib44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.32074\/1591-951X-942","article-title":"Think \u201cHER2\u201d different: integrative diagnostic approaches for HER2-low breast cancer","volume":"115","author":"Marchi\u00f2","year":"2023","journal-title":"Pathologica"},{"key":"10.1016\/j.prp.2025.156068_bib45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00428-015-1868-7","article-title":"Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry","volume":"468","author":"Helin","year":"2016","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2025.156068_bib46","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s43018-022-00436-4","article-title":"Artificial intelligence in histopathology: enhancing cancer research and clinical oncology","volume":"3","author":"Shmatko","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.prp.2025.156068_bib47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/jimaging8080213","article-title":"HEROHE challenge: predicting her2 status in breast cancer from hematoxylin\u2013eosin whole-slide imaging","volume":"8","author":"Conde-Sousa","year":"2022","journal-title":"J. Imaging"},{"key":"10.1016\/j.prp.2025.156068_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2022.102486","article-title":"SlideGraph+: Whole slide image level graphs to predict HER2 status in breast cancer","volume":"80","author":"Lu","year":"2022","journal-title":"Med. Image Anal."},{"key":"10.1016\/j.prp.2025.156068_bib49","doi-asserted-by":"crossref","first-page":"i79","DOI":"10.1093\/bioinformatics\/btae236","article-title":"PhiHER2: phenotype-informed weakly supervised model for HER2 status prediction from pathological images","volume":"40","author":"Yan","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.prp.2025.156068_bib50","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13058-024-01863-0","article-title":"Weakly-supervised deep learning models enable HER2-low prediction from H &E stained slides","volume":"26","author":"Valieris","year":"2024","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.prp.2025.156068_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12967-024-06034-5","article-title":"Deep learning-based prediction of HER2 status and trastuzumab treatment efficacy of gastric adenocarcinoma based on morphological features","volume":"23","author":"Wu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2025.156068_bib52","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10120-021-01215-3","article-title":"Landscape of EBV-positive gastric cancer","volume":"24","author":"Saito","year":"2021","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.prp.2025.156068_bib53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s12885-020-07013-x","article-title":"Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis","volume":"20","author":"Tavakoli","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2025.156068_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.583463","article-title":"EBV-positive gastric cancer: current knowledge and future perspectives","volume":"10","author":"Sun","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2025.156068_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1525-1578(10)60642-3","article-title":"Molecular diagnosis of epstein-barr virus-related diseases","volume":"3","author":"Gulley","year":"2001","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.prp.2025.156068_bib56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jmv.2152","article-title":"Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma","volume":"66","author":"Hoshikawa","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.prp.2025.156068_bib57","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3748\/wjg.v11.i5.629","article-title":"P. Zhao, Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas","volume":"11","author":"Luo","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2025.156068_bib58","first-page":"14","article-title":"Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A","volume":"28","author":"Truong","year":"2009","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.prp.2025.156068_bib59","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.1016\/S2589-7500(21)00133-3","article-title":"Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study","volume":"3","author":"Muti","year":"2021","journal-title":"Lancet Digit. Health"},{"key":"10.1016\/j.prp.2025.156068_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22731-x","article-title":"Deep learning model to predict Epstein-Barr virus associated gastric cancer in histology","volume":"12","author":"Jeong","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156068_bib61","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36408","article-title":"Prediction of Epstein-Barr Virus status in gastric cancer biopsy specimens using a deep learning algorithm","volume":"5","author":"Vuong","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.prp.2025.156068_bib62","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1038\/s41467-022-30459-5","article-title":"A deep learning model and human-machine fusion for prediction of EBV-associated gastric cancer from histopathology","volume":"13","author":"Zheng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2025.156068_bib63","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3390\/ijms23052462","article-title":"Artificial intelligence for predicting microsatellite instability based on tumor histomorphology: a systematic review","volume":"23","author":"Park","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156068_bib64","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5230\/jgc.2023.23.e5","article-title":"Comprehensive study of microsatellite instability testing and its comparison with immunohistochemistry in gastric cancers","volume":"23","author":"Park","year":"2023","journal-title":"J. Gastric Cancer"},{"key":"10.1016\/j.prp.2025.156068_bib65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-019-0738-1","article-title":"Mismatch repair deficiency\/microsatellite instability-high as a predictor for anti-PD-1\/PD-L1 immunotherapy efficacy","volume":"12","author":"Zhao","year":"2019","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2025.156068_bib66","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","article-title":"ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach","volume":"30","author":"Luchini","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2025.156068_bib67","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2353\/jmoldx.2008.080031","article-title":"Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome","volume":"10","author":"Shia","year":"2008","journal-title":"J. Mol. Diagn. JMD"},{"key":"10.1016\/j.prp.2025.156068_bib68","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00418-023-02202-8","article-title":"Evaluating mismatch repair deficiency in colorectal cancer biopsy specimens","volume":"160","author":"Grillo","year":"2023","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.prp.2025.156068_bib69","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.3390\/cancers14092204","article-title":"Microsatellite status detection in gastrointestinal cancers: PCR\/NGS is mandatory in negative\/patchy mmr immunohistochemistry","volume":"14","author":"Zito Marino","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.156068_bib70","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1159\/000531003","article-title":"The day-to-day practice of MMR and MSI assessment in colorectal adenocarcinoma: what we know and what we still need to explore","volume":"41","author":"Parente","year":"2023","journal-title":"Dig. Dis."},{"key":"10.1016\/j.prp.2025.156068_bib71","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.5858\/arpa.2021-0632-CP","article-title":"Mismatch repair and microsatellite instability testing for immune checkpoint inhibitor therapy: guideline from the college of american pathologists in collaboration with the Association for Molecular Pathology and Fight Colorectal Cancer","volume":"146","author":"Bartley","year":"2022","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2025.156068_bib72","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41591-019-0462-y","article-title":"Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer","volume":"25","author":"Kather","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2025.156068_bib73","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1038\/s41467-020-17678-4","article-title":"A deep learning model to predict RNA-Seq expression of tumours from whole slide images","volume":"11","author":"Schmauch","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2025.156068_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2024.105685","article-title":"Accuracy of machine learning in diagnosing microsatellite instability in gastric cancer: A systematic review and meta-analysis","volume":"193","author":"Ying","year":"2025","journal-title":"Int. J. Med. Inf."},{"key":"10.1016\/j.prp.2025.156068_bib75","article-title":"Computational analysis of pathological image enables interpretable prediction for microsatellite instability","volume":"12","author":"Zhu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2025.156068_bib76","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1053\/j.gastro.2020.06.021","article-title":"Clinical-grade detection of microsatellite instability in colorectal tumors by deep learning","volume":"159","author":"Echle","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2025.156068_bib77","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.3390\/cancers14112590","article-title":"Recent applications of artificial intelligence from histopathologic image-based prediction of microsatellite instability in solid cancers: a systematic review","volume":"14","author":"Alam","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.156068_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109243","article-title":"An interpretable deep learning model for identifying the morphological characteristics of dMMR\/MSI-H gastric cancer","volume":"27","author":"Zheng","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.prp.2025.156068_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.2261","article-title":"Potential diagnostic, prognostic, and predictive biomarkers of gastric cancer","volume":"7","author":"Mohammed","year":"2024","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.prp.2025.156068_bib80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s42047-024-00162-4","article-title":"Advancements and challenges in gastric cancer: epidemiology, biomarkers, and therapeutic strategies","volume":"7","author":"Nishimuni","year":"2024","journal-title":"Surg. Exp. Pathol."},{"key":"10.1016\/j.prp.2025.156068_bib81","article-title":"Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: a literature review with expert opinion","volume":"254","author":"Angerilli","year":"2024","journal-title":"Pathol. - Res. Pr."},{"key":"10.1016\/j.prp.2025.156068_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100284","article-title":"Global ring study to investigate the comparability of total assay performance of commercial Claudin 18 antibodies for evaluation in gastric cancer","volume":"104","author":"Jasani","year":"2024","journal-title":"Lab. Invest"},{"key":"10.1016\/j.prp.2025.156068_bib83","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41416-019-0508-4","article-title":"Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases","volume":"121","author":"Coati","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2025.156068_bib84","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2147\/OTT.S282718","article-title":"Targeting FGFR2 positive gastroesophageal cancer: current and clinical developments","volume":"15","author":"Gordon","year":"2022","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.prp.2025.156068_bib85","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1200\/JCO.19.01834","article-title":"Phase I Escalation and expansion study of bemarituzumab (FPA144) in patients with advanced solid tumors and FGFR2b-selected gastroesophageal adenocarcinoma","volume":"38","author":"Catenacci","year":"2020","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.156068_bib86","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000441149","article-title":"Evaluation of fibroblast growth factor receptor 2 expression, heterogeneity and clinical significance in gastric cancer","volume":"82","author":"Han","year":"2015","journal-title":"Pathobiol. J. Immunopathol. Mol. Cell. Biol."},{"key":"10.1016\/j.prp.2025.156068_bib87","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/diagnostics10121060","article-title":"A \u2018real-life\u2019 experience on automated digital image analysis of FGFR2 immunohistochemistry in breast cancer","volume":"10","author":"Braun","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.prp.2025.156068_bib88","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.euf.2021.04.007","article-title":"Artificial Intelligence\u2013based Detection of FGFR3 mutational status directly from routine histology in bladder cancer: a possible preselection for molecular testing?","volume":"8","author":"Loeffler","year":"2022","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.prp.2025.156068_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55331-6","article-title":"AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer","volume":"15","author":"Bannier","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2025.156068_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.32074\/1591-951X-925","article-title":"Advances in radiology and pathology of prostate cancer: a review for the pathologist","volume":"116","author":"Pepe","year":"2024","journal-title":"Pathologica"},{"key":"10.1016\/j.prp.2025.156068_bib91","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/cyt.13412","article-title":"Computer-assisted urine cytology: faster, cheaper, better?","volume":"35","author":"Ciaparrone","year":"2024","journal-title":"Cytopathology"},{"key":"10.1016\/j.prp.2025.156068_bib92","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00428-023-03518-5","article-title":"Artificial intelligence\u2013assisted cancer diagnosis improves the efficiency of pathologists in prostatic biopsies","volume":"482","author":"Eloy","year":"2023","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2025.156068_bib93","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1470-2045(19)30738-7","article-title":"Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study","volume":"21","author":"Str\u00f6m","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2025.156068_bib94","article-title":"Deep learning for classification of colorectal polyps on whole-slide images","volume":"8","author":"Korbar","year":"2017","journal-title":"J. Pathol. Inf."},{"key":"10.1016\/j.prp.2025.156068_bib95","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s43018-020-0087-6","article-title":"Pan-cancer image-based detection of clinically actionable genetic alterations","volume":"1","author":"Kather","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.prp.2025.156068_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113335","article-title":"Deep learning trained on lymph node status predicts outcome from gastric cancer histopathology: a retrospective multicentric study","volume":"194","author":"Muti","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2025.156068_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103631","article-title":"Accurate diagnosis and prognosis prediction of gastric cancer using deep learning on digital pathological images: a retrospective multicentre study","volume":"73","author":"Huang","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.prp.2025.156068_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002730","article-title":"Predicting survival from colorectal cancer histology slides using deep learning: a retrospective multicenter study","volume":"16","author":"Kather","year":"2019","journal-title":"PLoS Med."},{"key":"10.1016\/j.prp.2025.156068_bib99","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(19)32998-8","article-title":"Deep learning for prediction of colorectal cancer outcome: a discovery and validation study","volume":"395","author":"Skrede","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2025.156068_bib100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/path.5898","article-title":"Artificial intelligence to identify genetic alterations in conventional histopathology","volume":"257","author":"Cifci","year":"2022","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2025.156068_bib101","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41591-018-0177-5","article-title":"Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning","volume":"24","author":"Coudray","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2025.156068_bib102","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1038\/s41598-019-43525-8","article-title":"Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma","volume":"9","author":"Harder","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2025.156068_bib103","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/s41379-022-01141-4","article-title":"Direct identification of ALK and ROS1 fusions in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning algorithms","volume":"35","author":"Mayer","year":"2022","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2025.156068_bib104","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1093\/bioinformatics\/btac456","article-title":"DEMoS: a deep learning-based ensemble approach for predicting the molecular subtypes of gastric adenocarcinomas from histopathological images","volume":"38","author":"Wang","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.prp.2025.156068_bib105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13244-025-01905-x","article-title":"Guiding AI in radiology: ESR\u2019s recommendations for effective implementation of the European AI Act","volume":"16","author":"Kotter","year":"2025","journal-title":"Insights Imaging"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T14:36:07Z","timestamp":1753799767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825002614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":105,"alternative-id":["S0344033825002614"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156068","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemical biomarker scoring in gastroesophageal cancers: Can computers help us?","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156068"}}